title: In vivo targeting of leukemia stem cells by directing parthenolide-loaded nanoparticles to the bone marrow niche.
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
authors.forename: H
authors.initials: H
authors.lastname: Zong
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
authors.forename: S
authors.initials: S
authors.lastname: Sen
authors.affiliation: Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX, USA.
authors.forename: G
authors.initials: G
authors.lastname: Zhang
authors.affiliation: Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX, USA.
authors.forename: C
authors.initials: C
authors.lastname: Mu
authors.affiliation: University of Arkansas for Medical Sciences, College of Pharmacy, Little Rock, AR, USA.
authors.forename: Z F
authors.initials: ZF
authors.lastname: Albayati
authors.affiliation: Institute of Molecular Medicine, The University of Texas-Houston Medical School, Houston, TX, USA.
authors.forename: D G
authors.initials: DG
authors.lastname: Gorenstein
authors.affiliation: Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX, USA.
authors.forename: X
authors.initials: X
authors.lastname: Liu
authors.affiliation: Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX, USA.|Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
authors.forename: M
authors.initials: M
authors.lastname: Ferrari
authors.affiliation: University of Arkansas for Medical Sciences, College of Pharmacy, Little Rock, AR, USA.
authors.forename: P A
authors.initials: PA
authors.lastname: Crooks
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
authors.forename: G J
authors.initials: GJ
authors.lastname: Roboz
authors.affiliation: Department of Nanomedicine, The Methodist Hospital Research Institute, Houston, TX, USA.|Department of Cell and Developmental Biology, Weill Cornell Medical College, New York, NY, USA.
authors.forename: H
authors.initials: H
authors.lastname: Shen
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY, USA.
authors.forename: M L
authors.initials: ML
authors.lastname: Guzman
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D001853:Bone Marrow / Q000187:drug effects; D045744:Cell Line, Tumor; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D051379:Mice; D016688:Mice, Inbred NOD; D016513:Mice, SCID; D053758:Nanoparticles; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D012717:Sesquiterpenes / Q000008:administration & dosage*; D055153:Stem Cell Niche / Q000187:drug effects; D023041:Xenograft Model Antitumor Assays
chemical_list: D000970:Antineoplastic Agents; D012717:Sesquiterpenes; C002669:parthenolide